ING 151 (Pantoprazole Sodium Delayed-Release 40 mg)
Pill with imprint ING 151 is Yellow, Capsule-shape and has been identified as Pantoprazole Sodium Delayed-Release 40 mg. It is supplied by Ingenus Pharmaceuticals, LLC.
Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; gerd; gastritis/duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ING 151
Pantoprazole Sodium Delayed-Release
- Imprint
- ING 151
- Strength
- 40 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ingenus Pharmaceuticals, LLC
- Manufacturer
- Laboratories Liconsa S.A.
- National Drug Code (NDC)
- 50742-0151
More about pantoprazole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 232 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (4)
Consumer resources
- Pantoprazole
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Delayed-Release Granules
- Pantoprazole Injection
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
Other brands: Protonix, Protonix IV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
